Periodic Reporting for period 1 - ALISE (Anti-Cancer Light-Controllable Antibody-Peptide Conjugates)

Project ALISE (Antibody Light-Induced Selectivity Enhancement) integrates the expertise, resources and knowledge of participating Institutions focusing on design, synthesis and preclinical study of conjugates of monoclonal antibodies with peptides whose anti-cancer activity...